KRAS G13S [plasma membrane]

Stable Identifier
R-HSA-9649642
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
plasma membrane
Locations in the PathwayBrowser
Expand all
Literature References
PubMed ID Title Journal Year
18070147 BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma

Costa, AM, Herrero, A, Fresno, MF, Heymann, J, Alvarez, JA, Cameselle-Teijeiro, J, García-Rostán, G

Clin. Endocrinol. (Oxf) 2008
17697521 No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations

Kimura, K, Nagasaka, T, Hoshizima, N, Sasamoto, H, Notohara, K, Takeda, M, Kominami, K, Iishii, T, Tanaka, N, Matsubara, N

J. Int. Med. Res. 2007
27888800 Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms

Lee, YJ, Lee, MY, Ruan, A, Chen, CK, Liu, HP, Wang, CJ, Chao, WR, Han, CP

Oncotarget 2016
19824059 Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma

Abubaker, J, Bavi, P, Al-Haqawi, W, Sultana, M, Al-Harbi, S, Al-Sanea, N, Abduljabbar, A, Ashari, LH, Alhomoud, S, Al-Dayel, F, Uddin, S, Al-Kuraya, KS

J. Pathol. 2009
External Reference Information
External Reference
UniProt:P01116 KRAS
Gene Names
KRAS, KRAS2, RASK2
Chain
initiator methionine:1, chain:1-186, chain:2-186, propeptide:187-189
Reference Genes
BioGPS Gene:3845 KRAS
COSMIC (genes):KRAS KRAS
CTD Gene:3845 KRAS
dbSNP Gene:3845 KRAS
ENSEMBL:ENSG00000133703 KRAS
HGNC:6407 KRAS
KEGG Gene (Homo sapiens):3845 KRAS
Monarch:3845 KRAS
NCBI Gene:3845 KRAS
OMIM:190070 KRAS
UCSC:P01116 KRAS
Reference Transcript
Other Identifiers
0006110070
0007040129
11717962_x_at
11717963_a_at
11717964_a_at
11717965_s_at
16762399
1940_at
204009_s_at
204010_s_at
214352_s_at
231640_at
32159_at
3447860
3447862
3447864
3447865
3447866
3447867
3447868
3447869
3447870
3447871
3447872
3447873
3447874
3447879
3447880
3447884
3447886
3845
3958621
7961865
A_23_P306500
A_23_P306507
A_23_P45140
A_33_P3317815
GE61031
GO:0000003
GO:0000165
GO:0000166
GO:0001889
GO:0001934
GO:0002223
GO:0002376
GO:0003674
GO:0003924
GO:0005515
GO:0005525
GO:0005575
GO:0005622
GO:0005737
GO:0005739
GO:0005829
GO:0005886
GO:0005925
GO:0006464
GO:0006950
GO:0007010
GO:0007165
GO:0007265
GO:0007267
GO:0007565
GO:0007568
GO:0008150
GO:0008219
GO:0008283
GO:0008284
GO:0008542
GO:0009058
GO:0010628
GO:0016020
GO:0019002
GO:0019003
GO:0019221
GO:0021897
GO:0030036
GO:0030154
GO:0030275
GO:0031234
GO:0031647
GO:0032228
GO:0034641
GO:0035022
GO:0035900
GO:0038002
GO:0042592
GO:0043167
GO:0043226
GO:0043406
GO:0043524
GO:0044877
GO:0045121
GO:0045596
GO:0048169
GO:0048856
GO:0048873
GO:0050877
GO:0051000
GO:0051092
GO:0051146
GO:0051384
GO:0051385
GO:0060441
GO:2000774
Hs.184050.0.S1_3p_a_at
Hs.184050.1.A1_3p_a_at
Hs.184050.4.A1_3p_at
ILMN_1652104
ILMN_1728071
M54968_at
PH_hs_0028364
PH_hs_0030345
TC12001314.hg
g4826811_3p_a_at
Participant Of
hasCandidate
Other forms of this molecule
KRAS A146T [plasma membrane]
KRAS K147E [plasma membrane]
KRAS K147T [plasma membrane]
KRAS V14G [plasma membrane]
KRAS K147N [plasma membrane]
KRAS A146V [plasma membrane]
KRAS A146S [plasma membrane]
KRAS A146P [plasma membrane]
KRAS P34R [plasma membrane]
KRAS P34L [plasma membrane]
KRAS G12A [plasma membrane]
KRAS G12R [plasma membrane]
KRAS G13V [plasma membrane]
KRAS G13C [plasma membrane]
KRAS G13R [plasma membrane]
KRAS G13A [plasma membrane]
KRAS K5N [plasma membrane]
KRAS G12S [plasma membrane]
KRAS Q61L [plasma membrane]
KRAS Q61K [plasma membrane]
KRAS Q61R [plasma membrane]
KRAS F156L [plasma membrane]
KRAS G12C [plasma membrane]
KRAS L19F [plasma membrane]
KRAS G12D [plasma membrane]
KRAS Q22E [plasma membrane]
KRAS K117N [plasma membrane]
KRAS Q22R [plasma membrane]
KRAS Q61H [plasma membrane]
KRAS V14I [plasma membrane]
KRAS G12V [plasma membrane]
KRAS D153V [plasma membrane]
KRAS G13D [plasma membrane]
KRAS T58I [plasma membrane]
KRAS G60R [plasma membrane]
KRAS D33E [plasma membrane]
KRAS Q22K [plasma membrane]
KRAS G60V [plasma membrane]
KRAS G60D [plasma membrane]
KRAS E63K [plasma membrane]
KRAS A59T [plasma membrane]
KRAS [plasma membrane]
proKRAS [cytosol]
S-Farn-proKRAS [endoplasmic reticulum membrane]
S-Farn-Me KRAS [endoplasmic reticulum membrane]
S-Farn-KRAS [endoplasmic reticulum membrane]
Modified Residues
Name
glycine 13 replaced with L-serine
Coordinate
13
PsiMod
L-serine residue [MOD:00025]
A protein modification that effectively converts a source amino acid residue to L-serine.
glycine removal [MOD:01638]
A protein modification that effectively removes or replaces an glycine.
Disease
Name Identifier Synonyms
ovarian cancer 2394 ovarian neoplasm, malignant tumour of ovary, neoplasm of ovary (disorder), ovary neoplasm, primary malignant neoplasm of ovary and other uterine adnexa (disorder), ovarian cancer, tumor of the Ovary, ovary cancer, malignant Ovarian tumor, primary ovarian cancer, malignant tumor of ovary (disorder)
colorectal cancer 9256
thyroid carcinoma 3963 head and neck cancer, Thyroid
Cross References
RefSeq
COSMIC
OpenTargets
ZINC - Substances
HPA
GeneCards
ZINC target
Ensembl
PRO
Orphanet
PDB
6GQT, 6B0Y, 4EPT, 5V6S, 6QUV, 5UQW, 6FA2, 1N4R, 5O2S, 6EPL, 4LYH, 4LRW, 5V6V, 5OCT, 4M1Y, 6MBQ, 6P8W, 6BOF, 6P8Z, 5USJ, 6CC9, 6N2J, 5V9L, 5YY1, 6GOG, 5OCG, 6N2K, 6FA4, 5XCO, 5VQ6, 6QUW, 5WLB, 1N4P, 6GJ6, 5V9U, 6MBU, 4M22, 4LYF, 4DSO, 6E6F, 5VQ1, 6GOD, 5MLA, 5WHD, 6MQN, 4WA7, 6BP1, 4EPR, 6ASA, 5US4, 4LUC, 5OCO, 6GQY, 4QL3, 4PZY, 6EPN, 6FA1, 4Q02, 6QUX, 4LDJ, 1N4Q, 6H47, 6GOF, 5O2T, 1N4S, 6FA3, 5VBM, 5TAR, 6EPP, 6P0Z, 5KYK, 5VQ0, 5MLB, 5WHB, 5VP7, 6PGP, 6E6G, 4M1W, 6P8X, 6GJ7, 3GFT, 6B0V, 6ASE, 6OIM, 5WPM, 6F76, 6M9W, 6MQG, 4DSN, 6OB2, 6GOE, 5V71, 6ARK, 6GJ5, 6CCH, 4OBE, 5V9O, 4EPX, 1D8D, 4LYJ, 6GOM, 5UFE, 5VPI, 4NMM, 4TQ9, 6EPM, 4EPY, 5VPY, 4LPK, 5VQ8, 5YXZ, 1KZO, 4Q01, 6EPO, 5F2E, 5UK9, 4L8G, 6CU6, 6PGO, 4M1O, 6GQW, 4EPV, 6OB3, 5W22, 5UFQ, 5VQ2, 1D8E, 6CCX, 4LV6, 4PZZ, 6GJ8, 4Q03, 5VPZ, 4EPW, 5WHE, 4M1S, 6GQX, 6QUU, 4TQA, 5WHA, 6MBT, 5TB5, 6H46, 1KZP, 6P8Y, 6V5L, 4M1T, 4M21
Interactors (2)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  54 0.623 5
 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate [ChEBI:16618]  6 0.462 2
Cite Us!